Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Johnston

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Cancer|May 10, 2022
A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancerNadia Harbeck, Harold J Burstein, Sara A Hurvitz, et al.
JAMA Network Open|June 16, 2026
Sociodemographic, Health Care, and Clinical Factors Associated With Metabolic Bariatric Surgery Uptake Among US Adults With ObesityRafeya V Raquib, Allison Tokarski, Ishita Doshi, et al.
Andrology|October 3, 2023
The relationship between sperm nuclear DNA fragmentation, mitochondrial DNA fragmentation, and copy number in normal and abnormal human ejaculatesAna Tímermans, Fátima Otero, Manuel Garrido, et al.
Andrologia|November 27, 2021
Antibiotic toxicity on human spermatozoa assessed using the sperm DNA fragmentation dynamic assayAna Tímermans, Rosana Vázquez, Fátima Otero, et al.
Annals of Human Genetics|September 8, 2018
Association of polymorphisms in genes coding for antioxidant enzymes and human male infertilityAnaís García Rodríguez, Moises de la Casa, Stephen Johnston, et al.
Current Medical Research and Opinion|October 14, 2011
Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinibBeth Sherrill, Bintu Sherif, Mayur M Amonkar, et al.
Frontiers in Behavioral Neuroscience|December 16, 2014
Real-time fMRI brain-computer interface: development of a "motivational feedback" subsystem for the regulation of visual cue reactivityMoses O Sokunbi, David E J Linden, Isabelle Habes, et al.
Journal of Hospital Medicine|December 23, 2011
Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patientsAlpesh N Amin, Helen Varker, Nicole Princic, et al.
Hospital Practice (1995)|May 18, 2011
Retrospective administrative database study of the time period of venous thromboembolism risk during and following hospitalization for major orthopedic or abdominal surgery in real-world US patientsAlpesh N Amin, Greg Lenhart, Nicole Princic, et al.
The Oncologist|August 28, 2010
Quality of life in hormone receptor-positive HER-2+ metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinibBeth Sherrill, Mayur M Amonkar, Bintu Sherif, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Cancer|May 10, 2022
A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancerNadia Harbeck, Harold J Burstein, Sara A Hurvitz, et al.
JAMA Network Open|June 16, 2026
Sociodemographic, Health Care, and Clinical Factors Associated With Metabolic Bariatric Surgery Uptake Among US Adults With ObesityRafeya V Raquib, Allison Tokarski, Ishita Doshi, et al.
Andrology|October 3, 2023
The relationship between sperm nuclear DNA fragmentation, mitochondrial DNA fragmentation, and copy number in normal and abnormal human ejaculatesAna Tímermans, Fátima Otero, Manuel Garrido, et al.
Andrologia|November 27, 2021
Antibiotic toxicity on human spermatozoa assessed using the sperm DNA fragmentation dynamic assayAna Tímermans, Rosana Vázquez, Fátima Otero, et al.
Annals of Human Genetics|September 8, 2018
Association of polymorphisms in genes coding for antioxidant enzymes and human male infertilityAnaís García Rodríguez, Moises de la Casa, Stephen Johnston, et al.
Current Medical Research and Opinion|October 14, 2011
Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinibBeth Sherrill, Bintu Sherif, Mayur M Amonkar, et al.
Frontiers in Behavioral Neuroscience|December 16, 2014
Real-time fMRI brain-computer interface: development of a "motivational feedback" subsystem for the regulation of visual cue reactivityMoses O Sokunbi, David E J Linden, Isabelle Habes, et al.
Journal of Hospital Medicine|December 23, 2011
Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patientsAlpesh N Amin, Helen Varker, Nicole Princic, et al.
Hospital Practice (1995)|May 18, 2011
Retrospective administrative database study of the time period of venous thromboembolism risk during and following hospitalization for major orthopedic or abdominal surgery in real-world US patientsAlpesh N Amin, Greg Lenhart, Nicole Princic, et al.
The Oncologist|August 28, 2010
Quality of life in hormone receptor-positive HER-2+ metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinibBeth Sherrill, Mayur M Amonkar, Bintu Sherif, et al.
Pageof 14